Perspectives d’élimination de la tuberculose : la stratégie OMS à l’épreuve de la pandémie de COVID-19

Tuberculosis (TB) remains a major global public health problem according to the World Health Organization (WHO). In 2020, TB was the second leading cause of death from a single infectious agent, after COVID-19. The End TB strategy adopted by WHO in 2014 aims to achieve a 95% reduction in TB mortality and 90% reduction in incidence by 2035 compared to 2015 rates. After nearly 20 years of steady decline in TB incidence worldwide (2% on average), the COVID-19 pandemic has had a significant impact in terms of reversing the global TB situation. Indeed, for the first time in more than a decade, there has been a net increase in TB deaths and a re-increase in the number of estimated new cases. However, the COVID-19 pandemic also provides a starting point for the adoption of new technological solutions, multisectoral collaboration, and resource sharing to strengthen overall health systems.